Auster Martin's Form 4 filing
Ventyx Biosciences, Inc. (VTYX) · filed Apr 5, 2023
- Accession no.
- 0001209191-23-023474
- Filed
- Apr 5, 2023
- Trade date
- Apr 4, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $646.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Auster MartinCIK 0001875786 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 4, 2023 | Common Stock | MOption exerciseAcquired | +21,000 | $3.45 | +$72,450 | 68,649 | Direct | |
| Apr 4, 2023 | Common Stock | SSaleDisposed | −9,577 | $30.24F2 | −$289,608.48 | 59,072 | Direct | |
| Apr 4, 2023 | Common Stock | SSaleDisposed | −9,535 | $31.07F3 | −$296,252.45 | 49,537 | Direct | |
| Apr 4, 2023 | Common Stock | SSaleDisposed | −1,888 | $31.86F4 | −$60,151.68 | 47,649 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 4, 2023 | Common Stock | MOption exerciseDisposed | −21,000 | $0.00 | $0 | 310,184 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average share price of an aggregate total of 9,577 shares sold in the price range of $29.6844 to $30.6732. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average share price of an aggregate total of 9,535 shares sold in the price range of $30.6899 to $31.6704. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average share price of an aggregate total of 1,888 shares sold in the price range of $31.685 to $32.145. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.